JP2023527048A5 - - Google Patents
Info
- Publication number
- JP2023527048A5 JP2023527048A5 JP2022572748A JP2022572748A JP2023527048A5 JP 2023527048 A5 JP2023527048 A5 JP 2023527048A5 JP 2022572748 A JP2022572748 A JP 2022572748A JP 2022572748 A JP2022572748 A JP 2022572748A JP 2023527048 A5 JP2023527048 A5 JP 2023527048A5
- Authority
- JP
- Japan
- Prior art keywords
- protein
- protein according
- fusion protein
- seq
- pharmaceutical composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNPCT/CN2020/092613 | 2020-05-27 | ||
| CN2020092613 | 2020-05-27 | ||
| PCT/CN2021/075907 WO2021238302A1 (zh) | 2020-05-27 | 2021-02-08 | 一种白细胞介素29突变体蛋白 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023527048A JP2023527048A (ja) | 2023-06-26 |
| JP2023527048A5 true JP2023527048A5 (https=) | 2023-10-03 |
| JP7741108B2 JP7741108B2 (ja) | 2025-09-17 |
Family
ID=78745522
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022572748A Active JP7741108B2 (ja) | 2020-05-27 | 2021-02-08 | インターロイキン２９変異体タンパク質 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20230265144A1 (https=) |
| EP (1) | EP4159748A4 (https=) |
| JP (1) | JP7741108B2 (https=) |
| CN (1) | CN115667291B (https=) |
| AU (1) | AU2021280623B9 (https=) |
| WO (1) | WO2021238302A1 (https=) |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW201138808A (en) * | 2010-05-03 | 2011-11-16 | Bristol Myers Squibb Co | Serum albumin binding molecules |
| CN109293782A (zh) * | 2014-01-08 | 2019-02-01 | 德益阳光生物技术（北京）有限责任公司 | 融合多肽及使用方法 |
| CN103923209B (zh) * | 2014-05-13 | 2016-06-22 | 北京凯因科技股份有限公司 | 一种Lambda干扰素突变体及聚乙二醇衍生物 |
| CN105085658B (zh) * | 2014-05-14 | 2019-12-24 | 杭州先为达生物科技有限公司 | 一种白细胞介素29突变体及聚乙二醇衍生物 |
| CN105085657A (zh) * | 2014-05-14 | 2015-11-25 | 北京凯因科技股份有限公司 | 一种干扰素突变体及聚乙二醇衍生物 |
| CN112694526B (zh) * | 2020-05-27 | 2023-01-20 | 杭州先为达生物科技有限公司 | 一种白细胞介素29突变体蛋白 |
| CN112870336B (zh) * | 2021-02-24 | 2022-06-14 | 杭州先为达生物科技有限公司 | 一种白细胞介素29突变体蛋白制剂 |
-
2021
- 2021-02-08 CN CN202180037021.9A patent/CN115667291B/zh active Active
- 2021-02-08 AU AU2021280623A patent/AU2021280623B9/en active Active
- 2021-02-08 JP JP2022572748A patent/JP7741108B2/ja active Active
- 2021-02-08 EP EP21812837.9A patent/EP4159748A4/en active Pending
- 2021-02-08 US US17/999,884 patent/US20230265144A1/en active Pending
- 2021-02-08 WO PCT/CN2021/075907 patent/WO2021238302A1/zh not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US10442845B2 (en) | Interferon analogs | |
| EP3319633B1 (en) | Vaccine against rsv | |
| RU2016103067A (ru) | Улучшенные аминокислотные последовательности, направленные против респираторно-синцитиального вируса человека (hrsv), и полипептиды, включающие такие последовательности, для профилактики и/или лечения инфекций дыхательных путей | |
| CN109641034A (zh) | 聚乙二醇化的猪干扰素及其使用方法 | |
| JP2018510622A5 (https=) | ||
| JP2025184979A5 (https=) | ||
| JP2014506450A5 (https=) | ||
| JPWO1996028475A1 (ja) | Ｐｅｇ化ｈｇｆ | |
| US20250057927A1 (en) | Alpha-1 antitrypsin produced from yeast for use in the treatment of viral infections | |
| CA2695805C (en) | Synthetic pulmonary surfactant protein b peptides | |
| US20130237476A1 (en) | Adipose tissue targeted peptides | |
| JP2023527048A5 (https=) | ||
| CN101671390B (zh) | 人干扰素α衍生物及其聚乙二醇化修饰物的制备和用途 | |
| WO2021164576A1 (zh) | 用于抗冠状病毒感染的药物及其应用 | |
| JP2008518622A5 (https=) | ||
| JP2023522423A (ja) | インターフェロンアルファ２バリアント及びその使用 | |
| US20250002548A1 (en) | Wild Boar Cathelicidin Peptide Variants and Vectors Encoding the Same for Uses in Managing Coronavirus Infections | |
| JP2008532518A (ja) | 昆虫細胞において産生される組換えｅ−セレクチン | |
| CA3213403A1 (en) | Modified chimeric coronavirus spike protein for enhancement of viral titers | |
| CN118434880A (zh) | 由酵母生产的α-1抗胰蛋白酶用于治疗病毒感染的用途 | |
| HK40051815A (en) | Vaccine against rsv comprising modified f polypeptide | |
| HK1250939B (en) | Vaccine against rsv | |
| JP2011020926A (ja) | 修飾ペプチド及びその製造方法 | |
| JP2001269184A5 (https=) |